The study will use NantHealth's GPS Cancer test to help treat adult and pediatric brain cancer patients.
Researchers find that genetic testing of pediatric brain cancer can uncover clinically relevant alterations, Technology Review reports.
The study showed that targeted sequencing was feasible, identified many clinically relevant alterations, and directed effective targeted therapy in several cases.
The researchers used genome and epigenomic data to identify distinct subtypes of a lethal pediatric cancer, as well as potential drug candidates.
The researchers found that 80 percent of pediatric posterior fossa ependymomas have decreased levels of H3K27me3 histone modifications.
The funds will support TGen's efforts to use graphics processing units to reduce single-cell transcriptome data analysis times from months to days.
By analyzing the transcriptomes of more than 4,000 individual cells, researchers identified stem cell-like cellular subpopulations in six oligodendroglioma tumors.
NantHealth, CHOP, and their collaborators intend to release genomic, transcriptomic, and proteomic data from 1,600 patients in the next six months
A retrospective review of panel sequencing data presented at the National Society of Genetic Counselors conference linked BRCA2 to primary brain cancer cases.
A team of German researchers identified the four-microRNA signature and said it might inform treatment decisions.
In Science this week: intellectual property landscape of CRISPR genome editing, and more.
A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.
Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.
Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.